Dallah Healthcare Co

SAU:4004 (Saudi Arabia)  
ï·¼ 164.40 (+0.74%) Jun 6
41.03
P/B:
4.75
Market Cap:
ï·¼ 16.06B ($ 4.28B)
Enterprise V:
ï·¼ 17.77B ($ 4.74B)
Volume:
65.97K
Avg Vol (2M):
80.71K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Dallah Healthcare Co ( ) from 2012 to Jun 08 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Dallah Healthcare stock (SAU:4004) PE ratio as of Jun 08 2024 is 41.03. More Details

Dallah Healthcare Co (SAU:4004) PE Ratio (TTM) Chart

To

Dallah Healthcare Co (SAU:4004) PE Ratio (TTM) Historical Data

Total 1278
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 15
Dallah Healthcare PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-08 41.7 2024-03-28 44.8
2024-06-06 41.7 2024-03-27 48.1
2024-06-05 41.4 2024-03-26 48.4
2024-06-04 42.1 2024-03-25 47.6
2024-06-03 42.2 2024-03-24 47.8
2024-06-02 41.7 2024-03-21 48.5
2024-05-30 41.7 2024-03-20 47.5
2024-05-29 41.7 2024-03-19 48.0
2024-05-28 41.6 2024-03-18 49.3
2024-05-27 41.7 2024-03-17 48.8
2024-05-26 41.7 2024-03-14 49.2
2024-05-23 42.2 2024-03-13 50.5
2024-05-22 42.4 2024-03-12 49.4
2024-05-21 42.1 2024-03-11 49.4
2024-05-20 42.7 2024-03-10 49.8
2024-05-19 42.1 2024-03-07 49.7
2024-05-16 42.1 2024-03-06 49.0
2024-05-15 42.4 2024-03-05 49.5
2024-05-14 42.6 2024-03-04 49.5
2024-05-13 42.8 2024-03-03 50.0
2024-05-12 42.4 2024-02-29 50.7
2024-05-09 42.1 2024-02-28 50.4
2024-05-08 42.6 2024-02-27 49.5
2024-05-07 40.9 2024-02-26 50.3
2024-05-06 40.8 2024-02-25 50.5
2024-05-05 41.0 2024-02-21 50.0
2024-05-02 41.1 2024-02-20 50.8
2024-05-01 41.1 2024-02-19 49.2
2024-04-30 41.4 2024-02-18 48.5
2024-04-29 41.3 2024-02-15 48.6
2024-04-28 41.4 2024-02-14 49.5
2024-04-25 41.4 2024-02-13 47.5
2024-04-24 42.0 2024-02-12 47.8
2024-04-23 42.2 2024-02-11 47.6
2024-04-22 42.7 2024-02-08 48.3
2024-04-21 43.0 2024-02-07 48.3
2024-04-18 43.1 2024-02-06 46.8
2024-04-17 42.6 2024-02-05 45.6
2024-04-16 43.5 2024-02-04 45.1
2024-04-15 43.3 2024-02-01 44.6
2024-04-04 44.0 2024-01-31 44.6
2024-04-03 44.2 2024-01-30 43.7
2024-04-02 44.0 2024-01-29 44.9
2024-04-01 43.5 2024-01-28 46.0
2024-03-31 42.5 2024-01-25 46.8

Dallah Healthcare Co (SAU:4004) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines and retail of medical and surgical equipment, prosthetics and devices for the disabled, hospital equipment and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants and the packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Services/Medicine and Pharmaceutical products. The majority of the company's revenue is earned from the Medical service segment.